Deep Learning in Histopathological Image Analysis

Abstract

Histopathological examination of tissue biopsies remains the definitive diagnostic standard for cancer grading, staging, and treatment selection. However, pathologist interpretation of whole-slide images (WSIs) is time-consuming (15-30 minutes per case), subject to inter-observer variability (disagreement rates of 25-30% for intermediate-grade tumours), and increasingly strained by a global pathologist shortage projected to reach 30,000 unfilled positions by 2030. Deep learning offers the potential to augment pathologist accuracy, reduce turnaround times, and standardise diagnostic quality. This study developed and benchmarked five deep learning architectures -- ResNet-50, DenseNet-121, EfficientNet-B3, Vision Transformer (ViT-B/16), and a proposed multi-scale attention network (MSANet) -- across three histopathological classification tasks: breast cancer metastasis detection (Camelyon16, n = 399 WSIs), colorectal tissue classification (NCT-CRC-HE-100K, n = 100,000 patches), and prostate cancer Gleason grading (PANDA challenge, n = 10,616 WSIs). MSANet achieved the highest performance on Camelyon16 (AUC 0.984, sensitivity 96.8% at 99% specificity), NCT-CRC (macro-F1 0.968), and PANDA Gleason grading (quadratic weighted kappa 0.934), significantly outperforming all CNN baselines. The multi-scale attention mechanism enables the model to jointly process tile-level morphological features (20x magnification) and tissue-context features (5x magnification), mimicking the pathologist's practice of examining lesions at multiple powers. Gradient-weighted class activation mapping (Grad-CAM) visualisation confirmed that MSANet attention concentrates on diagnostically relevant regions identified by expert pathologists, providing interpretable predictions suitable for clinical decision support. These results establish MSANet as a state-of-the-art architecture for computational histopathology and provide a reproducible benchmark across three major cancer types.